Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04862481
Other study ID # SJ758
Secondary ID 8045-00052B
Status Completed
Phase
First received
Last updated
Start date January 25, 2021
Est. completion date September 12, 2021

Study information

Verified date March 2022
Source University College Absalon
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

When choosing outcomes to assess rehabilitation's effect or progress, it is essential to consider the constructs being measured and their value to the patient and the psychometric properties. Choosing an outcome that reflects all aspects of International Classification levels of Functioning, Disability and Health (ICF) is challenging, especially in heterogeneous groups. However, it is important to know the psychometric properties as this gives important knowledge on how to interpret results and, consequently, how this can inform the patient's care. The Short Musculoskeletal Function Assessment (SMFA) questionnaire can reflect differences in patients' functional status with a broad range of disorders, like for elderly citizens undergoing municipality-based rehabilitation. Nevertheless, since there is no golden standard to measure rehabilitation outcomes, construct validity needs to be established to investigate how scores of SMFA can be related to measures on all levels of ICF. Therefore, this study has three main objectives: 1. To investigate how scores of the SMFA questionnaire are related to measures on different ICF levels 2. To describe the characteristics of older citizens starting municipality-based rehabilitation on all ICF levels 3. To investigate predictor variables of upper- and lower extremity strength


Description:

The present study is a sub-study to the Randomized Controlled Trial (NCT04091308). The present study aims to include 115 participants who will undergo measures specified in the "Outcome" section. The principal investigator of the study will conduct the testing.


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date September 12, 2021
Est. primary completion date September 10, 2021
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: All citizens that are referred to the health/rehabilitation center aged = 65 years from Slagelse municipality will be invited to a screening interview with a physiotherapist after which the participant will be asked to join the study if not subject to one of the following exclusion criteria's: Exclusion Criteria: - Inability to speak or read Danish, - Active cancer, - Upper or lower limb amputations, - Hypertension >180/110, - Referred to rehabilitation primarily due to gynecological or neurological conditions (apoplexies) or surgeries where movement restrictions prohibit participating in most of the tests, - Discouragement from a general practitioner.

Study Design


Locations

Country Name City State
Denmark Sundhed og Træning Slagelse Zealand

Sponsors (4)

Lead Sponsor Collaborator
University College Absalon Danish Council for Independent Research, Sundhed og Træning, Slagelse Municipality, University of Southern Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Measure of mobility with The New Mobility Score The New Mobility Score assesses the patient's walking function inside, outside, and during shopping. Including whether a walking aid is used. The NMS provides a composed score of the participants' mobility. Each question is scored between 0-3 points, depending on the degree of help. The total possible score is between 0 and 9 points. Baseline
Other Measure of the PRISMA-7 score The PRISMA-7 questionnaire is composed of seven items and is used to indicate frailty among participants - each question scores either 0 or 1 points. The total possible score is between 0 and 7 points. Baseline
Other Measure of the Tilburg Frailty Scale score The Tilburg Frailty Scale is a questionnaire with a bio-psycho-social approach, which measures frailty. It is composed of 15 multidimensional questions, regarding the physical, psychological, and social aspects of human functioning.
Scoring range is between 0-15 points.
Baseline
Other Measure of pain (region of pain, intensity of pain, duration of pain), physical activity level and demographic information A survey with self-formulated questions regarding name, sex, personal ID (CPR number), educational level, the region of pain the last three months (marked on a body chart), pain intensity and pain duration at the most painful body region the last three months, and physical activity level will also be collected. Baseline
Other Measure of weight Weight will be measured in kilograms Baseline
Other Measure of height Height will be measured in meters Baseline
Other Measure of blood pressure Systolic and diastolic blood pressure (mmHg) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor. Baseline
Other Measure of resting heart rate Resting heart rate (in beats per minute) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor. Baseline
Other Measure of lean body mass The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms. Baseline
Other Measure of fat percentage The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms.
Fat percentage will be measured as a percentage of the total body mass.
Baseline
Other Measure of total body water The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms.
Total body water will be measured as percentage of the total body mass.
Baseline
Other Measure of visceral fat The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass will be measured in kilograms.
Visceral fat will be measured on a scale ranging between 1-59. Scores above 12 indicate an unhealthy level of visceral fat.
Baseline
Other Measure of basic metabolic rate (BMR) BMR will be estimated by a bioelectrical impedance analysis device "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyze" in kilojoules. Baseline
Other Measure of Waist-To-Hip ratio The circumference of the waist (in centimeters) will be divided with the circumference of the hip (in centimeters) to report the Waist-to-hip ratio. Baseline
Other Measure of maximal isometric voluntary contraction of leg extension A maximal isometric voluntary contraction (in newtons) for knee extension will be performed using a strain gauge. Baseline
Other Measure of handgrip strength The handgrip strength (in kilograms) will be measured using a hydraulic handgrip dynamometer (SAEHAN). Baseline
Other Measure of shoulder strength The shoulder abduction strength (in kilograms) will be measured using a handheld dynamometer. Baseline
Other Measure of elbow strength The elbow flexion and extension strength (in kilograms) will be measured using a handheld dynamometer. Baseline
Other Measure of leg press strength Five repetitions maximum (RM) strength tests will be performed in the leg press (in kilograms) to calculate one RM. Baseline
Other Measure of knee extension strength Five repetitions maximum (RM) strength tests will be performed in knee extension (in kilograms) to calculate one RM. Baseline
Other Measure of calf extension strength Five repetitions maximum (RM) strength tests will be performed in the calf extension (in kilograms) to calculate one RM Baseline
Other Measure of gait distance with the two minutes walk test (2MWT) The 2MWT will measure the distance (in meters) a person can walk in two minutes. Gaits speed will be calculated by dividing the covered distance with the time (two minutes). Baseline
Other Measure of heart rate before and after the two minutes walk test (2MWT) Heart rate (in BPM) will be measured (using the Apple Watch serie 5) before and right after the 2MWT. Baseline
Other Measure of Rating Perceived Exertion using The Borg Scale before and after the two minutes walk test (2MWT) The Borg Rating of Perceived Exertion 6-20 scale will be used to estimate the activity intensity before and right after the 2MWT. Higher numbers indicate higher exertion. Baseline
Other Measure of function using the Timed Up and Go test (TUG) Time is noted (in seconds) on how long it takes to get up from a chair, walk three meters, turn around and go back to the chair and sit down again. Baseline
Other Measure of balance using the Tandem test A measure of static balance will be performed using a Tandem test. The participants will be tested in three positions for ten seconds each (feet together, semi tandem and full tandem). Time is noted (in seconds) for how long the participant can stand in each position Baseline
Other Measure of balance and reaction time for upper and lower extremity Measures for balance and reaction time will be collected using the "Fysiometer," and the protocols within the "Fysiometer" software will be followed. Baseline
Other Estimation of protein and energy intake Protein and energy intake will be estimated based on 24-hour dietary recall interviews. Baseline
Primary Measure of physical functioning with Short Musculoskeletal Function Assessment (SMFA) Self reported Baseline
Secondary Measure in health-related quality of life with Short Form 36 (SF-36) The SF-36 is a generic questionnaire that measures health-related quality of life in the past four weeks. The questionnaire consists of 36 questions which are divided into eight sub-scales and summarized in two sum scores. Higher scores indicate better health status. Baseline
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Active, not recruiting NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Active, not recruiting NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A